- About GRP
- Resource Center
- RI Platform
- Contact Us
In South Korea, a rare disease is defined as a disease or condition that affects less than 20,000 patients among Korean population residing in South Korea. An orphan drug is a drug used to treat a rare disease or a disease with no available treatment in Korea. The orphan drugs are supplied to patients by pharmaceutical companies or Korea Orphan Drug Center.
Global Regulatory Partners Inc, (GRP) is an American company that provides regulatory affairs, clinical, quality and safety services to medical devices and pharmaceutical companies globally. GRP headquarters is located in Massachusetts USA and its main affiliates are located in China, Japan, Brazil, Mexico and South Korea GRP helps many life science companies register their products in different countries in compliance with local regulations.